-
FDA pushes back target date for review of Takeda drug in patients with ulcerative colitis
DEERFIELD, Ill. — The Food and Drug Administration has postponed the time it will decide whether or not to approve an experimental treatment under development by Takeda Pharmaceutical Co. for ulcerative colitis, the company said.
-
Alka-Seltzer Fruit Chews revive brand
WHIPPANY, N.J. — Thanks in part to the launch of Alka-Seltzer Fruit Chews, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category. Brand sales are up 422.4% to $7.2 million for the 52 weeks ended Oct. 6, according to IRI data across total U.S. multi-outlets.